Baxter International Inc
BAX· NYSE
Released Aug 6, 2024, before the open
10-Q filed Aug 6, 2024, 37 days after period end · 0001628280-24-034965
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $2.69B | $2.59B | $3.59B | $3.10B |
| Net Income | -$314.00M | -$141.00M | $252.00M | $298.00M |
| EPS Diluted |
Baxter International Inc · CIK 10456 · Engraved from SEC EDGAR
| -$0.61 |
| -$0.28 |
| $0.50 |
| $0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.